Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RISE: Ranibizumab for Diabetic Macular Edema
NCT00473330Phase 3Completed
- Sponsor
- Genentech
- Start
- Jun 2007
- Primary completion
- Nov 2010
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of ranibizumab in diabetic macular edema (DME), sponsored by Genentech. Started Jun 2007; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00473330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473330.